Gene · 6752
Papers3,968
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,968
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Responses to medical treatment in patients with metastatic unresectable small intestinal neuroendocrine tumors - A single center study of 378 patients. | J Neuroendocrinol | 2026 | 41709663 | PubTator, text mining | PubMed |
| Somatostatin receptor PET in meningioma: diagnosis, therapy, and surveillance. | Nucl Med Commun | 2026 | 41693498 | PubTator, text mining | PubMed |
| Structural and dynamic insights into ligand recognition and activation of somatostatin receptor 3. | Acta Pharmacol Sin | 2026 | 41673456 | PubTator, text mining | PubMed |
| A Phase 0 Imaging Trial of [203Pb]Pb-VMT-α-NET to Enable Dosimetry and Treatment Planning for Refractory or Relapsed Metastatic Neuroendocrine Tumors with [212Pb]Pb-VMT-α-NET. | J Nucl Med | 2026 | 41644295 | PubTator, text mining | PubMed |
| Preoperative Metabolic Predictors of Granulation Subtypes in Somatotroph Tumors: A Multicenter Retrospective Cohort Study. | CNS Neurosci Ther | 2026 | 41631367 | PubTator, text mining | PubMed |
| Impact of neuroendocrine neoplasm-specific systemic treatments on expression and function of CXCR4 in neuroendocrine tumor cells. | Sci Rep | 2026 | 41620429 | PubTator, text mining | PubMed |
| 68GA DOTATATE PET in Schwannomas: Distinct Avidity Pattern Supporting Noninvasive Diagnosis. | AJNR Am J Neuroradiol | 2026 | 41617401 | PubTator, text mining | PubMed |
| A case of radiation treatment effect mimicking viable, recurrent meningioma on DOTATATE PET imaging. | Neurooncol Adv | 2026 | 41613044 | PubTator, text mining | PubMed |
| Alpha Therapy Beyond TOC and TATE-Production, Quality Control, and In-Human Results for the SSTR2 Antagonist DOTA-LM3. | Pharmaceuticals (Basel) | 2026 | 41599769 | PubTator, text mining | PubMed |
| Multidimensional lung imaging: integrated preclinical platforms enabling the identification of translational biomarkers for pulmonary research. | Respir Res | 2026 | 41572273 | PubTator, text mining | PubMed |
| [177Lu]Lu-DOTA-TATE tumour and organ time-activity curves: prediction from a single-time-point [68Ga]Ga-DOTA-TATE PET/CT measurement. | EJNMMI Phys | 2026 | 41540179 | PubTator, text mining | PubMed |
| Cabergoline monotherapy in GH- and PRL-cosecreting pituitary adenomas. | Endocr Oncol | 2026 | 41532055 | PubTator, text mining | PubMed |
| [Clinicopathological and molecular characteristics of clear cell meningioma: analyses of seventeen cases]. | Zhonghua Bing Li Xue Za Zhi | 2026 | 41490640 | PubTator, text mining | PubMed |
| Idiopathic hypertrophic pachymeningitis masquerading as CNS neoplasm: case report and literature review. | Immunol Res | 2026 | 41483370 | PubTator, text mining | PubMed |
| Preclinical and Initial Clinical Evaluation of 68Ga/177Lu-Labeled Heterodimer Agents Targeting Somatostatin Receptors and Integrin αVβ3. | Mol Pharm | 2026 | 41404947 | PubTator, text mining | PubMed |
| Macrocyclic and Hydroxamate Ligands for 225Ac Radiopharmaceuticals: Evaluating SSTR2-Targeting Potential. | Inorg Chem | 2026 | 41381404 | PubTator, text mining | PubMed |
| The Current Status of Nuclear Medicine in Africa. | J Nucl Med | 2026 | 41381238 | PubTator, text mining | PubMed |
| Distribution of Somatostatin and Its Receptors in the Intestinal Tract in Healthy Patients and Patients with Type 2 Diabetes. | J Clin Endocrinol Metab | 2026 | 41379811 | PubTator, text mining | PubMed |
| Altered somatostatin receptor 3 expression and functional dysregulation in tuberous sclerosis complex. | Prog Neurobiol | 2026 | 41352576 | PubTator, text mining | PubMed |
| Clinical and Pathological Spectrum of Acromegaly: Distinguishing GH PitNETs, Mammosomatotrophs, and Mixed Tumors. | J Clin Endocrinol Metab | 2026 | 41296644 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6752/papers?page=6